Literature DB >> 900333

Primary adenocarcinoma of the small intestine.

D F Morgan, R W Busuttil.   

Abstract

Eighteen cases of primary adenocarcinoma of the small intestine have been reviewed, which demonstrated the relative frequency of symptoms common to this disease. The clinical features, pathology, and treatment of small bowel adenocarcinoma have been presented and the literature reviewed.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 900333     DOI： 10.1016/0002-9610(77)90399-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


  9 in total

1.  Enteric adenoma and adenocarcinoma.

Authors:  M J Cooper; R C Williamson
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

2.  Primary adenocarcinoma of the jejunum and ileum: clinicopathological review of 25 cases.

Authors:  T F Lioe; J D Biggart
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

3.  Recent advances in the management of adenocarcinoma of the small intestine.

Authors:  Michael J Overman
Journal:  Gastrointest Cancer Res       Date:  2009-05

4.  Primary adenocarcinoma of duodenal bulb benefitted by chemotherapy.

Authors:  T Ohkusa; K Ohtomo; N Yamamoto; H Fujimoto
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

5.  Primary small intestinal adenocarcinoma diagnosed by endoscopic examination prior to operation.

Authors:  M Watatani; N Yasuda; H Imamoto; K Tamura; I Mori; T Hara
Journal:  Gastroenterol Jpn       Date:  1989-08

6.  Adenocarcinoma of the small intestine: 21-year review of diagnosis, treatment, and prognosis.

Authors:  R L Bauer; M L Palmer; A M Bauer; H R Nava; H O Douglass
Journal:  Ann Surg Oncol       Date:  1994-05       Impact factor: 5.344

7.  Primary jejunoileal tumors: a review of 45 cases.

Authors:  L A Desa; J Bridger; P A Grace; T Krausz; J Spencer
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

8.  A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma.

Authors:  Takahiro Horimatsu; Norisuke Nakayama; Toshikazu Moriwaki; Yoshinori Hirashima; Mikio Fujita; Masako Asayama; Ichiro Moriyama; Koji Nakashima; Eishi Baba; Hiroshi Kitamura; Takao Tamura; Ayumu Hosokawa; Kenichi Yoshimura; Manabu Muto
Journal:  Int J Clin Oncol       Date:  2017-05-23       Impact factor: 3.402

Review 9.  Adjuvant chemotherapy for small intestine adenocarcinoma.

Authors:  N Singhal; D Singhal
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.